术中MRI与内镜实现垂体腺瘤全切率的系统综述
所有垂体腺瘤的汇总全切率三组相似;在大腺瘤亚组中,eTSS+iMRI的全切率较高。术后脑脊液漏比例三组相似。无法进行直接统计比较。
要点
- 所有垂体腺瘤中,eTSS、mTSS+iMRI和eTSS+iMRI的全切率相似。
- 垂体大腺瘤亚组中,eTSS+iMRI的全切率高于eTSS和mTSS+iMRI。
- 术后脑脊液漏比例在三组间相似,无直接统计比较。
核心结论
- 使用显微镜联合iMRI或内镜(联合或不联合iMRI)的最终全切比例相似。
- 两种技术对垂体大腺瘤的获益可能互补。
研究设计与样本
- 遵循PRISMA标准的系统综述,检索PubMed和Embase数据库。
主要发现
- 所有垂体腺瘤:eTSS汇总全切率68.9%(95%CI 64.7-73.0%),mTSS+iMRI为68.3%(95%CI 59.4-76.5%),eTSS+iMRI为70.7%(95%CI 56.9-89.6%)。
- 垂体大腺瘤亚组:eTSS全切率59.4%(95%CI 49.6-68.7%),mTSS+iMRI为68.8%(95%CI 57.3-79.3%),eTSS+iMRI为81.1%(95%CI 75.5-86.2%)。
- 术后脑脊液漏比例:eTSS为4.7%(95%CI 3.6-5.9%),eTSS+iMRI为3.7%(95%CI 1.6-6.5%),mTSS+iMRI为4.6%(95%CI 2.0-8.3%)。
临床怎么用
- 选择显微镜联合iMRI或内镜(联合或不联合iMRI)时,需考虑两者全切率相似。
- 对于垂体大腺瘤,eTSS+iMRI可能提高全切率。
局限性
- 无法进行直接统计比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative magnetic resonance imaging (iMRI) is a technology that may improve rates of gross total resection (GTR) for pituitary adenomas. The endoscope is another less expensive technology, which also may maximize resection rates. A direct comparison of these approaches and their additive benefit has never been performed. METHODS: A systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) standard. PubMed and Embase databases were searched for studies that examined GTR for pituitary adenoma resection with either endoscopic transsphenoidal surgery (eTSS), microscopic transsphenoidal surgery with iMRI (mTSS + iMRI), or endoscopic transsphenoidal surgery with iMRI (eTSS + iMRI). RESULTS: Eighty-five studies that reported GTR rates in 7124 pituitary adenoma patients were identified. For all pituitary adenomas, eTSS had a pooled proportion of GTR of 68.9% (95% CI 64.7-73.0%) which was similar to that of mTSS + iMRI (GTR 68.3%; 95% CI = 59.4-76.5%) and eTSS + iMRI (GTR 70.7%; 95% CI = 56.9-89.6%). For the subgroup of pituitary macroadenomas, pooled proportions for GTR were similar between eTSS and mTSS + iMRI (eTSS: GTR 59.4%; 95% CI = 49.6-68.7% vs mTSS + iMRI: GTR 68.8%; 95% CI = 57.3-79.3%), and higher for eTSS + iMRI (81.1%; 95% CI = 75.5-86.2%). The post-operative CSF leak proportion for eTSS (4.7%; 95% CI = 3.6-5.9%) was similar to that for eTSS + iMRI (3.7%; 95% CI = 1.6-6.5%) and mTSS + iMRI (4.6%; 95% CI = 2.0-8.3%). No direct statistical comparisons could be performed. CONCLUSION: Final GTR proportions are similar whether the surgeon uses a microscope supplemented with iMRI or endoscope with or without iMRI. The benefit of the two technologies may be complementary for macroadenomas. These findings are important to consider when comparing the efficacy of different technical strategies in the management of pituitary adenomas.
引用
- Soneru CP, Riley CA, Hoffman K, et al. Intra-operative MRI vs endoscopy in achieving gross total resection of pituitary adenomas: a systematic review. Acta Neurochir (Wien). 2019. PMID: 31139934. doi:10.1007/s00701-019-03955-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。